Metraipolis › archive › dc_5a0fff9febef
Interleukin-17 in disease pathogenesis and therapy: recent advances in targeted drug design and medicinal chemistry — Europe PMC PMID:42568824
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42568824
- DOI
- 10.3389/fphar.2026.1836187
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T06:48:08.261Z
- SHA-256 of the archived text
0fb71c366b345f8ea348ce4f61d9178051811902a79926abf0879f444fe28d51- Stable URL of this page
https://metraipolis.com/documento/dc_5a0fff9febef
How to cite
Interleukin-17 in disease pathogenesis and therapy: recent advances in targeted drug design and medicinal chemistry — Europe PMC PMID:42568824 — Europe PMC (en), https://europepmc.org/article/MED/42568824 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5a0fff9febef (Metraipolis archive dc_5a0fff9febef, sha256 0fb71c366b345f8ea348ce4f61d9178051811902a79926abf0879f444fe28d51)
BibTeX
@misc{dc5a0fff9febef,
title = {Interleukin-17 in disease pathogenesis and therapy: recent advances in targeted drug design and medicinal chemistry — Europe PMC PMID:42568824},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42568824},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5a0fff9febef; sha256 0fb71c366b345f8ea348ce4f61d9178051811902a79926abf0879f444fe28d51},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42568824. Agents can read the archived copy with the MCP tool read_document.